India Launches Anti-Dumping Probe into Chinese Chemical Imports, Pharma Sector in Focus
reuters
New Delhi, March 18 (TheTrendingPeople): India has initiated an anti-dumping investigation into imports of ethyl chloroformate from China, amid concerns that the chemical is being sold at unfairly low prices, impacting domestic manufacturers.
The probe has been launched by the Directorate General of Trade Remedies under the Ministry of Commerce, following a complaint by Paushak Limited, which alleged “material injury” due to rising imports.
Ethyl chloroformate is a key organic intermediate widely used in pharmaceutical and agrochemical manufacturing. According to officials, the investigation will assess whether Chinese exporters are engaging in dumping practices — selling goods below fair market value — and whether duties are required to protect domestic industry.
The DGTR stated that its preliminary findings suggest the dumping margin is above the minimum threshold, indicating significant price undercutting by Chinese suppliers.
The investigation will cover the period from October 2024 to September 2025 and will involve inputs from exporters, importers, and other stakeholders before any final recommendation is made.
Paushak, identified as India’s sole domestic producer of ethyl chloroformate, has claimed that increasing imports from China have suppressed prices and affected profitability.
If the allegations are confirmed, the government may impose anti-dumping duties on the imports, similar to previous trade actions taken to curb low-cost inflows.
Notably, in December, India had already imposed tariffs of 11% to 13% on certain steel imports to counter cheap supplies, largely from China.
In a parallel move, the DGTR has also initiated a separate anti-dumping investigation into imports of hexamine from China, Russia, and the United Arab Emirates — another key chemical used in industrial and pharmaceutical processes.
The potential imposition of duties could have mixed implications across industries.
For domestic manufacturers like Paushak, the move could offer protection from price undercutting and help stabilise margins.
However, for pharmaceutical and agrochemical companies that rely on imported intermediates, higher import costs could increase production expenses, potentially affecting pricing and supply chains.
Trade analysts suggest that such investigations are part of India’s broader strategy to balance domestic manufacturing growth with import dependence, especially in critical sectors like chemicals and pharmaceuticals.
India has increasingly relied on anti-dumping measures to address concerns over cheap imports, particularly from China. These steps align with broader initiatives aimed at strengthening domestic manufacturing and reducing vulnerability in supply chains.
At the same time, such measures can influence bilateral trade dynamics and may invite responses from exporting countries.
Future Outlook
The DGTR will continue its investigation over the coming months, examining evidence from all parties involved.
If dumping and injury to domestic industry are established, the authority may recommend anti-dumping duties to the government, which will take the final decision.
The outcome of the probe is expected to have significant implications for India’s chemical, pharmaceutical, and agrochemical sectors.
The anti-dumping investigation into ethyl chloroformate imports marks another key step in India’s trade enforcement measures. As the probe unfolds, industry stakeholders will closely monitor its impact on pricing, supply chains, and domestic production.
Our Final Thoughts
India’s decision to investigate alleged dumping of a critical chemical highlights the growing importance of trade regulation in protecting domestic industries. While such measures can strengthen local manufacturing, they also raise important questions about cost implications for downstream sectors like pharmaceuticals and agriculture. Striking the right balance between protection and competitiveness will be crucial. As global supply chains evolve, India’s approach to trade remedies is likely to play a defining role in shaping its industrial future.